ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 5346074  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      OG713396 JP 2021089220-A/8: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 11 PRT synthetic construct
      OG714738 WO 2021112225-A/11: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 672 PRT Mus musculus
      OG713395 JP 2021089220-A/7: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 11 PRT synthetic construct
      OG714739 WO 2021112225-A/12: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 672 PRT Mus musculus
      OG714734 WO 2021112225-A/7: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 11 PRT synthetic construct
      OG713400 JP 2021089220-A/12: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 672 PRT Mus musculus
      OG713399 JP 2021089220-A/11: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 672 PRT Mus musculus
      OG714735 WO 2021112225-A/8: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER. 11 PRT synthetic construct
      DM115374 WO 2008156172-A/46: Double-stranded nucleic acid molecules suitable for prevention or treatment of uterine cancer, breast cancer, or bladder cancer, Agent for inhibiting cancer cell proliferation, and Medicine. 21 DNA synthetic construct
      BD162199 JP 2002173500-A/6: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. 24 DNA synthetic construct
      HZ455485 JP 2015213503-A/3: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 21 RNA synthetic construct
      HZ455493 JP 2015213503-A/11: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 22 DNA synthetic construct
      BD570838 JP 2002173500-A/8: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. 179 PRT Canis sp.
      DD183395 JP 2005192484-A/26: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 29 DNA synthetic construct
      DD183403 JP 2005192484-A/34: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 20 DNA synthetic construct
      DD183411 JP 2005192484-A/42: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 32 DNA synthetic construct
      DL464145 WO 2008072741-A/2: TEST METHOD FOR CANCER, KIT FOR TESTING CANCER, AND TEST MATERIAL FOR CANCER. 22 DNA synthetic construct
      DM163100 WO 2009037857-A/1: Agent for diagnosing or treating lung cancer, prostafe cancer, breast cancer and melanoma. 3769 DNA unidentified
      OG148743 JP 2019511469-A/5: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 1408 DNA synthetic construct
      OG600684 JP 2019511469-A/16: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 415 PRT Equus caballus
      OG600691 JP 2019511469-A/23: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 471 PRT synthetic construct
      OG600698 JP 2019511469-A/30: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 17 PRT synthetic construct
      OG600705 JP 2019511469-A/37: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 468 PRT synthetic construct
      OG600712 JP 2019511469-A/44: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 16 PRT Mus musculus
      OG600719 JP 2019511469-A/51: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 467 PRT synthetic construct
      OG600726 JP 2019511469-A/58: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 239 PRT synthetic construct
      OG600733 JP 2019511469-A/65: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS. 112 PRT synthetic construct
      OG614074 WO 2020246336-A/1: Markers for determining the effectiveness of application of cancer therapy including cancer immunotherapy to cancer patients and use thereof. 8 PRT Murine leukemia virus
      OG614076 WO 2020246336-A/3: Markers for determining the effectiveness of application of cancer therapy including cancer immunotherapy to cancer patients and use thereof. 9 PRT Murine leukemia virus
      DM115373 WO 2008156172-A/45: Double-stranded nucleic acid molecules suitable for prevention or treatment of uterine cancer, breast cancer, or bladder cancer, Agent for inhibiting cancer cell proliferation, and Medicine. 21 DNA synthetic construct
      Now loading
      PAGE TOP